FDA Center for Drug Evaluation & Research Issues Warning Letter to Kdc/one Chatsworth
September 23, 2026
September 23, 2026
WASHINGTON, Sept. 23 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to kdc/one Chatsworth Inc. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Peter F. Rawson, Vice President and General Manager, kdc/one Chatsworth, Inc., 20320 Prairie St., Chatsworth, CA 91311-6026, United States, prawson@kdc-one.com
Issuing Office: Center for Drug Evaluation and Research (CDER), U . . .
* * *
Recipient: Mr. Peter F. Rawson, Vice President and General Manager, kdc/one Chatsworth, Inc., 20320 Prairie St., Chatsworth, CA 91311-6026, United States, prawson@kdc-one.com
Issuing Office: Center for Drug Evaluation and Research (CDER), U . . .